
Lyudmila Bazhenova, MD, explains why the updated taletrectinib label does not change her practice and reviews new WCLC subgroup data in ROS1+ NSCLC.
Peers & Perspectives in Oncology
In separate, live virtual events, Vincent K. Lam, MD, and Chul Kim, MD, MPH, discuss molecular assays and treatment options for a patient with metastatic non–small cell lung cancer (NSCLC), with participants.
CASE SUMMARY
History of Present Illness
Medical, Family, and Social History
Focused Physical Examination
Initial Diagnostic Assessment
Diagnostic Procedure
Histopathology
CASE UPDATE
• Tissue next-generation sequencing (NGS) molecular profile report: EML4::ALK fusion
• Remainder of the broad-based panel: negative
Stay up to date on practice-changing data in community practice.
Subscribe




